期刊文献+

乳腺癌乙肝病毒阳性伴肝功能损害17例化疗及保肝治疗临床观察

The Clinical Observation of Chemotherapy and Protecting Liver Therapy in 17 Patients with Mammary Cancer and Hepatitis B Virus Positive Combined with Liver Function Damage
暂未订购
导出
摘要 目的研究乳腺癌合并有乙肝病毒阳性伴肝功能损害的治疗方法。方法用拉米夫定及联苯双脂与乳癌化疗联合应用治疗乳腺癌合并有乙肝病毒阳性伴肝功能损害的患者。结果459例乳腺癌患者中,有17例乙肝病毒阳性伴肝功能损害,该17例患者肝功能在2,3月内均恢复正常,乳腺癌术后巩固化疗均按时间疗程顺利完成。结论拉米夫定及联苯双脂与乳腺癌化疗联合运用,是保证合并有乙肝病毒阳性伴肝功能损害乳腺癌患者化疗顺利进行的有效方法,值得推广应用。 Objective To explore the treatment of mammary cancer and hepatitis B virus positive combined with liver function damage. Methods Lamivudine combined with DDB was used to treat the patients with mammary cancer and hepatitis B virus positive combined with liver function damage and consolidation chemotherapy was normally conducted. Results Among 459 patients, there were 17 cases with hepatitis B virus positive and live function damage. Liver fimction damage in the 17 patients was returned to normal in 2 to 3 months, and chemotherapy was conducted smoothly in time. Conclusion Lamivudine combined with DDB is an effective way to smooth chemotherapy for mammary cancer patients with hepatitis B virus positive and live function damage, which is worthy of being applied.
出处 《临床医学工程》 2010年第4期67-68,共2页 Clinical Medicine & Engineering
关键词 乳腺癌 肝功能损害 慢性乙型肝炎 拉米夫定 联苯双脂 Mammary cancer Liver function damage Chronic hepatitis B Lamivudine Dimethyl diphenyl bicarboxylate(DDB)
  • 相关文献

参考文献5

二级参考文献30

  • 1刘志毅,刘耕陶,张世馥.联苯双酯对人肝癌细胞株的诱导分化作用[J].中华医学杂志,1995,75(11):676-678. 被引量:24
  • 2李小琴,李文军.联苯双酯治疗抗癌药物肝损害的疗效观察[J].镇江医学院学报,1995,5(3):230-230. 被引量:1
  • 3陈少华.联苯双酯对转氨酶的可逆性抑制作用分析[J].航空军医,1996,24(1):12-13. 被引量:4
  • 4刘志毅,崔勤,刘耕陶.联苯双酯(DDB)对Bel-7402人肝癌细胞株一些表型的作用及其机理[J].药学学报,1996,31(2):101-106. 被引量:9
  • 5[1]Yuen MF,Hui CK,Cheng CC,et al.Long-term follow-up of interferon-alfa treatment in Chinese patients with chronic hepatitis B infection:the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complication.Hepatology,2001,34:139-145.
  • 6[2]Honkop P,de Man RA,Niesters HGM,et al.Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.Hepatology,2000,32:635-640.
  • 7[3]Schlm SW,Heathcote J,Cianciara J,et al.Lamivudine and a-interferon combination treatment of patients with chronic hepatits B infection:a randomized trial.Gut,2000,46:562-568.
  • 8[4]Serfaty LWR,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone:results of a pilot study.Hepatology,2001,34:573-577.
  • 9[5]Lau GKK,Tsiang M,Hou J,et al.Combination therapy with lamivudine and famciclovir for chronic hepatitis Binfected Chinese patients:a viral dynamics study.Hepatology,2000,32:394-399.
  • 10[6]Liaw YF,Tsai SL,Chien RN,et al.Prednisolone proming enhances Th 1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.Hepatology,2000,32:604-609.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部